FRED HUTCHINSON CANCER CENTER
COMIDAS Comparing Original Mexican Diets and Standard US Diets
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT01369173
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- Adult Acute Monoblastic Leukemia (M5a)Adult Erythroleukemia (M6a)Adult Pure Erythroid Leukemia (M6b)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Megakaryoblastic Leukemia (M7)Recurrent Adult Acute Myeloid LeukemiaAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)
- Interventions
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT01342887
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
- Conditions
- Interventions
- First Posted Date
- 2011-04-21
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT01339663
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
- Conditions
- Interventions
- First Posted Date
- 2011-04-15
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT01335932
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Gene Therapy for Fanconi Anemia
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT01331018
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS
- Conditions
- Interventions
- Procedure: Allogeneic Bone Marrow TransplantationProcedure: Allogeneic Hematopoietic Stem Cell TransplantationDrug: CyclosporineDrug: Fludarabine PhosphateBiological: Indium In 111 Anti-CD45 Monoclonal Antibody BC8Other: Laboratory Biomarker AnalysisDrug: Mycophenolate MofetilProcedure: Peripheral Blood Stem Cell TransplantationOther: Pharmacological StudyRadiation: Total-Body IrradiationRadiation: Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8
- First Posted Date
- 2011-02-21
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT01300572
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT01252667
- Locations
- 🇺🇸
Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸VA Puget Sound Health Care System, Seattle, Washington, United States
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Conditions
- Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell LymphomaAdult Myelodysplastic SyndromeAdult Non-Hodgkin LymphomaAggressive Non-Hodgkin LymphomaChildhood Acute Lymphoblastic LeukemiaChildhood Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia in Remission
- Interventions
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 77
- Registration Number
- NCT01251575
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇩🇰Rigshospitalet University Hospital, Copenhagen, Denmark
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Vitamin D, Diet and Activity Study
- Conditions
- Interventions
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 218
- Registration Number
- NCT01240213
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
- Conditions
- Interventions
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT01236885
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States